Clinical Trial Update: A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study evaluating a fixed-combination bimatoprost and brimonidine for chronic glaucoma or ocular hypertension has completed, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost (bimatoprost)
• Brimonidine (brimonidine)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26